Grant: Operating Grant - PA: HIV/AIDS Bridge Funding - Health Services/Pop Hlth Stream
University of Toronto
$100,000.00
Advancing New Prevention Technologies for HIV: Rectal Microbicide Acceptability among Men who have Sex with Men and Transgenders in Thailand
FY 2011-12
Summary
With over 30 million people living with HIV, and 2.6 million new HIV infections globally in 2009 alone, new prevention options are sorely needed to expand our prevention tool kit. Exciting recent research has demonstrated that use of antiretroviral medications--either in topical gels or oral tablets--can reduce the risk of HIV infection during unprotected sex. These results provide renewed impetus for the development of topical rectal microbicides. Topical rectal microbicides are products designed to be applied to the rectal mucosa to prevent or significantly reduce the chances of contracting HIV. Globally, men who have sex with men (MSM) are 20 times more likely to be living with HIV than the general population. Thailand, in particular, is at the forefront of a burgeoning and largely unchecked epidemic among MSM in Asia. Nevertheless, the promise of microbicides may be limited by a lack of social research and much needed evidence to bridge the widespread science-to-practice gap that exists for many medical technologies. In order to be effective in the real world beyond medical studies, any new prevention product must be acceptable and accessible to end-users. The proposed study is the first of its kind in Asia and the developing world; we use cutting-edge, integrated qualitative and quantitative approaches to provide evidence that supports the transfer of scientific advances in medical research studies into everyday practice and policy in a key global setting. The study engages local communities in the research process, with results designed to guide healthcare providers, public health officials, policymakers, advocacy organizations and communities. As HIV ultimately knows no borders, with costs to Canada in the millions annually to pay for expensive HIV treatments for Canadians and aid to developing countries, investment in social research on new prevention technologies is an ethical and cost effective response to reverse the most deadly epidemic of our time.
Department
Program
Operating Grant - PA: HIV/AIDS Bridge Funding - Health Services/Pop Hlth Stream
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
250749
Name
Newman Peter A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Gender and Health
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Gender, Sex & Health
Projecttitle
Advancing New Prevention Technologies for HIV: Rectal Microbicide Acceptability among Men who have Sex with Men and Transgenders in Thailand
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Operating Grant - PA: HIV/AIDS Bridge Funding - Health Services/Pop Hlth Stream
Keyworddelim
Discrete Choice Analysis; Hiv/Aids; Implementation Science; Knowledge Mobilization; Men Who Have Sex With Men; Microbicides; Mixed Methods Research; Social Ecological Model; Thailand; Transgender Women
Abstract
With over 30 million people living with HIV, and 2.6 million new HIV infections globally in 2009 alone, new prevention options are sorely needed to expand our prevention tool kit. Exciting recent research has demonstrated that use of antiretroviral medications--either in topical gels or oral tablets--can reduce the risk of HIV infection during unprotected sex. These results provide renewed impetus for the development of topical rectal microbicides. Topical rectal microbicides are products designed to be applied to the rectal mucosa to prevent or significantly reduce the chances of contracting HIV. Globally, men who have sex with men (MSM) are 20 times more likely to be living with HIV than the general population. Thailand, in particular, is at the forefront of a burgeoning and largely unchecked epidemic among MSM in Asia. Nevertheless, the promise of microbicides may be limited by a lack of social research and much needed evidence to bridge the widespread science-to-practice gap that exists for many medical technologies. In order to be effective in the real world beyond medical studies, any new prevention product must be acceptable and accessible to end-users. The proposed study is the first of its kind in Asia and the developing world; we use cutting-edge, integrated qualitative and quantitative approaches to provide evidence that supports the transfer of scientific advances in medical research studies into everyday practice and policy in a key global setting. The study engages local communities in the research process, with results designed to guide healthcare providers, public health officials, policymakers, advocacy organizations and communities. As HIV ultimately knows no borders, with costs to Canada in the millions annually to pay for expensive HIV treatments for Canadians and aid to developing countries, investment in social research on new prevention technologies is an ethical and cost effective response to reverse the most deadly epidemic of our time.
Competitiondate
201109
Approvedterm2
1 yr 0 mth
Pinamesdelim
Newman, Peter A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~